Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. (Q48488443): Difference between revisions
Jump to navigation
Jump to search
Created claim: main subject (P921): Alzheimer's disease (Q11081), #quickstatements; batch #2058 by User:Daniel Mietchen |
Edoderoobot (talk | contribs) Updated Item: nl-description, python code, logfile on https://goo .gl/BezTim |
||
| label / nl | label / nl | ||
Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. | |||
Revision as of 07:39, 18 May 2018
scientific article published in May 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. |
scientific article published in May 1998 |
Statements
1 reference
Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. (English)
1 reference
Alvarez A
1 reference
Alarcón R
1 reference
Opazo C
1 reference
Campos EO
1 reference
Muñoz FJ
1 reference
Calderón FH
1 reference
Dajas F
1 reference
Gentry MK
1 reference
Doctor BP
1 reference
De Mello FG
1 reference
Inestrosa NC
1 reference
1 May 1998
1 reference
1 reference
18
1 reference
9
1 reference
3213-3223
1 reference